Skip to main content

Table 1 Patient and mother baseline characteristics

From: Association of inflammatory biomarkers with subsequent clinical course in suspected late onset sepsis in preterm neonates

Variable

Total episodes (n = 480)

Age of the mother (years)

30 (18–43)

Hypertension Pregnancy Disorder (PIH/PE)

107 (22.3%)

Gestational diabetes

33 (6.9%)

pPROMa

85 (17.7%)

Maternal Fever

22 (4.6%)

Antenatal corticosteroid therapyb

 

 None

64 (13.3%)

 1 dose of betamethasone

113 (23.5%)

 2 doses of betamethasone

295 (61.5%)

Singleton

386 (80.4%)

Sex (male)

249 (51.9%)

Gestational Age (weeks)

26 + 3 (24 + 0 – 31 + 6)

Post menstrual age (weeks)

29 + 1 (24 + 4 – 51 + 3)

Birthweight (grams)

850 (445–2100)

Age at Evaluation (days)

13 (4–165)

IL-6 level at onset (pg/mL)

45 (2–1396700)

PCT level at onset (ng/mL)

0.67 (0.02 – 100)

CRP level at onset (mg/L)

3.45 (0.3 – 309.0)

Mortality

24 (5%)

Type of infection

 

 No infection

337 (70.2%)

 Culture negative

56 (11.7%)

 Culture proven sepsis

87 (18.1%)

 Gram positive (% of total proven sepsis)

63 (72%)

    CoNSc

42 (48%)

   S. aureus

14 (16%)

    Others

7 (8%)

 Gram negative (% of total proven sepsis)

24 (28%)

    E.Coli

17 (19%)

   Klebsiella

4 (5%)

   Others

3 (4%)

nSOFA score

 

nSOFA score at t = 12 h

0 (0–11)

Number of suspected episode

 

 1 suspected episode

84

 2 suspected episode

46

  > 2 suspected episodes

78

  1. aProlonged premature rupture of membranes
  2. bNumber of doses of antenatal betamethasone therapy
  3. cCoagulase negative staphylococci
  4. Values are medians (min–max range) or percentages